Registry of Toxic Effects of Chemical Substances (RTECS)
Toluene, p-nitro-
RTECS #
XT3325000CAS #
99-99-0Updated
September 201Molecular Weight
137.15Molecular Formula
C7H7NO2Synonyms
1-Methyl-4-nitrobenzene4-Methylnitrobenzene
4-Nitrotoluene
4-Nitrotoluol
Benzene, 1-methyl-4-nitro- (9CI)
NCI-C60537
Nitrotoluene, para-
para-Nitrotoluol
p-Methylnitrobenzene
p-Nitrotoluene
p-Nitrotoluene (ACGIH:OSHA)
PNT
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | ovary/hamster | 500 mg/L | EMMUEG 10(Suppl 10),1,1987 |
DNA Damage | testis/rat | 0.032 µmol/L | EMMUEG 44,179,2004 |
DNA repair | /Bacillus subtilis | 5 mg/disc | MUREAV 170,11,1986 |
mutation in microorganisms | /Salmonella typhimurium | 10 µg/plate (+/-enzymatic activation step) | ENMUDM 4,163,1982 |
sister chromatid exchange | ovary/hamster | 200 mg/L | EMMUEG 10(Suppl 10),1,1987 |
Unscheduled DNA Synthesis | liver/rat | 100 µg/L | EMMUEG 26,147,1995 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/rat | 30 mg/kg (1D prior to copulation) | Reproductive: Maternal effects: Uterus, cervix, vagina | JTEHD6 36,13,1992 |
oral/rat | 65793 mg/kg (13W male) | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) Reproductive: Paternal effects: Testes, epididymis, sperm duct | NTPTR* NIH-93-3346 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | lowest published toxic dose: 507150 mg/kg/105W- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Lung, Thorax, or Respiration: Tumors | NTIS** NIH No. 01-4432 |
oral/mouse | lowest published toxic dose: 438 gm/kg/2Y- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Lung, Thorax, or Respiration: Tumors | TXCYAC 183,221,2003 |
oral/rat | lowest published toxic dose: 91.3 gm/kg/2Y- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Reproductive: Other reproductive system tumors | TXCYAC 183,221,2003 |
oral/rat | lowest published toxic dose: 109.5 gm/kg/2Y- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Skin and Appendages: Tumors | TXCYAC 183,221,2003 |
oral/rat | lowest published toxic dose: 80850 mg/kg/105W- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Skin and Appendages: Tumors | NTIS** NIH No. 01-4432 |
oral/rat | lowest published toxic dose: 91875 mg/kg/105W- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Reproductive: Other reproductive system tumors | NTIS** NIH No. 01-4432 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/mouse | lethal concentration (50 percent kill): 419 mg/m3 | Brain and Coverings: Recordings from specific areas of CNS Liver: Fatty liver degeneration Blood: Methemoglobinemia- Carboxhemoglobinemia | GTPZAB 22(7),52,1978 |
inhalation/rat | lethal concentration (50 percent kill): 975 mg/m3 | Brain and Coverings: Recordings from specific areas of CNS Liver: Fatty liver degeneration Blood: Methemoglobinemia- Carboxhemoglobinemia | GTPZAB 22(7),52,1978 |
intraperitoneal/rat | lethal dose (50 percent kill): 940 mg/kg | Behavioral: Ataxia Lung, Thorax, or Respiration: Cyanosis Lung, Thorax, or Respiration: Respiratory stimulation | GISAAA 24(9),15,1959 |
oral/mouse | lethal dose (50 percent kill): 1231 mg/kg | NTIS** PB214-270 | |
oral/rabbit | lethal dose (50 percent kill): 1750 mg/kg | Brain and Coverings: Recordings from specific areas of CNS Liver: Fatty liver degeneration Blood: Methemoglobinemia- Carboxhemoglobinemia | GTPZAB 22(7),52,1978 |
oral/rat | lethal dose (50 percent kill): 1960 mg/kg | GTPZAB 25(8),50,1981 | |
skin/rat | lethal dose (50 percent kill): >16 gm/kg | Lung, Thorax, or Respiration: Other changes Liver: Fatty liver degeneration Nutritional and Gross Metabolic: Weight loss or decreased weight gain | GISAAA 24(9),15,1959 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | lowest published toxic dose: 73983 mg/kg/13W- continuous | Liver: Changes in liver weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain | NTPTR* NIH-93-3346 |
oral/mouse | lowest published toxic dose: 8400 mg/kg/14D- intermittent | Liver: Changes in liver weight Endocrine: Changes in spleen weight Immunological Including Allergic: Decrease in humoral immune response | DCTODJ 17,317,1994 |
oral/mouse | lowest published toxic dose: 16800 mg/kg/4W- continuous | Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TXCYAC 183,221,2003 |
oral/mouse | lowest published toxic dose: 33600 mg/kg/8W- continuous | Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TXCYAC 183,221,2003 |
oral/mouse | lowest published toxic dose: 8400 mg/kg/14D- intermittent | Liver: Changes in liver weight Endocrine: Changes in spleen weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain | NTPTR* IMM-8703 |
oral/mouse | lowest published toxic dose: 8400 mg/kg/14D- intermittent | Immunological Including Allergic: Decrease in cellular immune response Immunological Including Allergic: Decreased immune response | NTPTR* IMM-8703 |
oral/mouse | lowest published toxic dose: 8400 mg/kg/2W- continuous | Liver: Other changes | CRNGDP 26,689,2005 |
oral/rat | lowest published toxic dose: 7000 mg/kg/4W- continuous | Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TXCYAC 183,221,2003 |
oral/rat | lowest published toxic dose: 40425 mg/kg/105W- continuous | Blood: Leukemia Tumorigenic: Active as anti-cancer agent | NTIS** NIHNo.01-4432 |
oral/rat | lowest published toxic dose: 176400 mg/kg/105W- continuous | Reproductive: Tumorigenic effects: Testicular tumors Tumorigenic: Active as anti-cancer agent | NTIS** NIHNo.01-4432 |
oral/rat | lowest published toxic dose: 194775 mg/kg/105W- continuous | Skin and Appendages: Tumors Tumorigenic: Active as anti-cancer agent | NTIS** NIHNo.01-4432 |
oral/rat | lowest published toxic dose: 65793 mg/kg/13W- continuous | Kidney, Ureter, and Bladder: Changes in bladder weight Blood: Changes in other cell count (unspecified) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases | NTPTR* NIH-93-3346 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 2 ppm (skin) | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Inadequate Evidence | IMEMDT 65,409,1996 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 65,409,1996 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 3 | IMEMDT 65,409,1996 |
TOXICOLOGY REVIEW | MUREAV 588,88,2005 | |
TOXICOLOGY REVIEW | MUTAEX 23,271,2008 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | time-weighted average 2 ppm (11 mg/m3), JUL2008 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 2 ppm (11 mg/m3), Skin, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 2 ppm (12 mg/m3), skin, MAY2011 | |
Occupational Exposure Limit-ICELAND | time-weighted average 2 ppm (12 mg/m3), skin, NOV2011 | |
Occupational Exposure Limit-MEXICO | time-weighted average 5 ppm (30 mg/m3);short term exposure limit 10 ppm (60 mg/m3), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 2 ppm (11 mg/m3), skin, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 1 ppm (5.5 mg/m3), JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 2 ppm (11 mg/m3), JUL2005 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) 3 mg/m4, MAC(short term exposure limit) 9 mg/m3, JAN1999 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 1 ppm (6 mg/m3);short term exposure limit 2 ppm (11 mg/m3), Skin, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 2 ppm (11 mg/m3), KZG-week 4 ppm (22 mg/m3), skin, JAN2011 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 5 ppm (30 mg/m3) (skin) | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 5 ppm (30 mg/m3) (skin) | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 5 ppm (30 mg/m3) (skin) | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 5 ppm (30 mg/m3) (skin) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO p-NITROTOLUENE-air | 10H time-weighted average 2 ppm (Sk) | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code X6955; Number of Industries 1; Total Number of Facilities 21; Number of Occupations 5; Total Number of Employees Exposed 4354; Total Number of Female Employees Exposed 729 |
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division